Sinovac Biotech Announces Extension of Deadline for Special Cash Dividend Payment Instructions

Sinovac Biotech Ltd. (NASDAQ: SVA) has announced an extension of the deadline for shareholders and nominee brokers to submit payment instructions for its previously declared special cash dividend. The special dividend of US$55.00 per common share was originally declared for valid holders as of May 23, 2025. While the company had initially set a submission deadline of December 31, 2025, for the necessary instruction materials, it has now extended this deadline to June 30, 2026. Shareholders and brokers who have not yet submitted their materials are urged to do so by the new date to facilitate payment. The company has directed inquiries regarding the payment process to its information agent, D.F. King & Co., Inc. Sinovac continues to focus on its core mission of developing and commercializing vaccines for infectious diseases, including its widely recognized portfolio covering COVID-19, hepatitis, and influenza. This administrative extension does not impact the company's clinical pipeline or ongoing research and development efforts.